Back
ePlus, Inc. 10K Form
Buy
59
PLUS
ePlus, Inc.
Last Price:
$90.14
Seasonality Move:
8.89%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-02-07 | 10Q | PLUS/ePlus, Inc. Quarterly |
| 2023-11-08 | 10Q | PLUS/ePlus, Inc. Quarterly |
| 2023-08-07 | 10Q | PLUS/ePlus, Inc. Quarterly |
| 2023-05-25 | 10K | PLUS/ePlus, Inc. Annual |
| 2023-02-07 | 10Q | PLUS/ePlus, Inc. Quarterly |
| 2022-11-03 | 10Q | PLUS/ePlus, Inc. Quarterly |
Receive PLUS News And Ratings
See the #1 stock for the next 7 days that we like better than PLUS
PLUS Financial Statistics
Sales & Book Value
| Annual Sales: | $2B |
|---|---|
| Cash Flow: | $-35.8M |
| Price / Cash Flow: | 26.46 |
| Annual Sales: | $39.38 |
| Price / Book: | 2.22 |
Profitability
| EPS (TTM): | 4.44360 |
|---|---|
| Net Income (TTM): | $114.6M |
| Gross Margin: | $514.5M |
| Return on Equity: | 11.57% |
| Return on Assets: | 6.43% |
ePlus, Inc. Earnings Forecast
Key ePlus, Inc. Financial Ratios
-
The Gross Profit Margin over the past 30 years for PLUS is 25.22%.
-
The Selling, General & Administrative Expenses for PLUS have been equal to 19.60% of Gross Profit Margin.
-
The Research & Development expenses have been 0.00% of Revenue.
-
The Interest Expense is 2.05% of Operating Income.
-
The Net Earning history of PLUS is 5.29% of Total Revenues.
-
Per Share Earnings over the last 30 years have been positive in 18 years.
ePlus, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Electronic Equipment, Instruments & Components |
| Sector: | Information Technology |
| Current Symbol: | PLUS |
| CUSIP: | 294268 |
| Website: | eplus.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 2.07 |
| Quick Ratio: | 1.72 |
Price-to-Earnings
| Trailing P/E Ratio: | 21.67 |
|---|---|
| Forward P/E Ratio: | 17.69 |
PLUS Technical Analysis vs Fundamental Analysis
Buy
59
ePlus, Inc. (PLUS)
is a Buy
Is ePlus, Inc. a Buy or a Sell?
-
ePlus, Inc. stock is rated a BuyThe current ePlus, Inc. [PLUS] share price is $87.73. The Score for PLUS is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.